120 related articles for article (PubMed ID: 9271509)
1. The dihydropyridine dexniguldipine hydrochloride inhibits cleavage and religation reactions of eukaryotic DNA topoisomerase I.
Straub T; Boesenberg C; Gekeler V; Boege F
Biochemistry; 1997 Sep; 36(35):10777-83. PubMed ID: 9271509
[TBL] [Abstract][Full Text] [Related]
2. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
[TBL] [Abstract][Full Text] [Related]
3. The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
Bailly C; Carrasco C; Hamy F; Vezin H; Prudhomme M; Saleem A; Rubin E
Biochemistry; 1999 Jul; 38(27):8605-11. PubMed ID: 10393535
[TBL] [Abstract][Full Text] [Related]
4. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.
Svejstrup JQ; Christiansen K; Gromova II; Andersen AH; Westergaard O
J Mol Biol; 1991 Dec; 222(3):669-78. PubMed ID: 1660929
[TBL] [Abstract][Full Text] [Related]
5. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
Labourier E; Riou JF; Prudhomme M; Carrasco C; Bailly C; Tazi J
Cancer Res; 1999 Jan; 59(1):52-5. PubMed ID: 9892183
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle.
Castelli S; Vassallo O; Katkar P; Che CM; Sun RW; Desideri A
Arch Biochem Biophys; 2011 Dec; 516(2):108-12. PubMed ID: 22033340
[TBL] [Abstract][Full Text] [Related]
7. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
Holden JA; Wall ME; Wani MC; Manikumar G
Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
[TBL] [Abstract][Full Text] [Related]
8. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
Komatani H; Morita M; Sakaizumi N; Fukasawa K; Yoshida E; Okura A; Yoshinari T; Nishimura S
Cancer Res; 1999 Jun; 59(11):2701-8. PubMed ID: 10363995
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the distinct role for the metal coordination motif in the catalytic activity of Mycobacterium smegmatis topoisomerase I.
Bhat AG; Leelaram MN; Hegde SM; Nagaraja V
J Mol Biol; 2009 Nov; 393(4):788-802. PubMed ID: 19733176
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
Klemm M; Cheng C; Cassell G; Shuman S; Segall AM
J Mol Biol; 2000 Jun; 299(5):1203-16. PubMed ID: 10873446
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation.
Stivers JT; Harris TK; Mildvan AS
Biochemistry; 1997 Apr; 36(17):5212-22. PubMed ID: 9136883
[TBL] [Abstract][Full Text] [Related]
13. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
14. Changing a leucine to a lysine residue makes NaeI endonuclease hypersensitive to DNA intercalative drugs.
Jo K; Topal MD
Biochemistry; 1996 Aug; 35(31):10014-8. PubMed ID: 8756463
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne.
Wang LK; Rogers BD; Hecht SM
Chem Res Toxicol; 1996; 9(1):75-83. PubMed ID: 8924619
[TBL] [Abstract][Full Text] [Related]
16. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
17. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of type IA topoisomerase by a monoclonal antibody through perturbation of DNA cleavage-religation equilibrium.
Leelaram MN; Bhat AG; Hegde SM; Manjunath R; Nagaraja V
FEBS J; 2012 Jan; 279(1):55-65. PubMed ID: 22008463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
